The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Medical Weekly, [S. l.], v. 131, n. 0304, p. 41–46, 2001. DOI: 10.4414/smw.2001.06144. Disponível em: https://smw.ch/index.php/smw/article/view/19. Acesso em: 5 nov. 2025.